Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from Operating Activities    
Net loss $ (1,140,360) $ (1,295,492)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation: 401(k) stock 16,462 8,507
Stock-based compensation: Options and warrants 168,649 103,581
Gain on foreign currency translation (19,003) (465)
Unrealized investment losses 399 957
Depreciation and amortization 36,930 46,161
Amortization of right-of-use asset 55,717
Amortization of debt discount 3,325
(Recovery of) provision for uncollectible assets (6,284) 9,609
Forgiveness of PPP Loan (242,486)
Decrease (increase) in assets:    
Accounts receivable (148,579) (16,115)
Inventory (85,825) (13,448)
Deposits 20,585
Prepaid expenses and other current assets (59,836) (23,627)
Increase (decrease) in liabilities:    
Accounts payable and accrued expenses (605,840) 110,573
Operating lease liabilities (59,185)
Deferred revenue (4,246) (2,712)
Other liabilities (5,651) 12,617
Total Adjustments (934,725) 235,495
Net Cash Used in Operating Activities (2,075,085) (1,059,997)
Cash Flows from Investing Activities    
Purchase of property and equipment (16,856) (16,789)
Net Cash Used in Investing Activities (16,856) (16,789)
Cash Flows from Financing Activities    
Proceeds from loans payable 27,641
Proceeds from loans payable - related parties 368,335
Repayments of loans payable (80,413) (20,677)
Proceeds from convertible debt obligations 725,000
Proceeds from underwritten public offering, net of offering costs [1] 7,287,004
Payment of offering costs (319,684)
Proceeds from sale of common stock and warrants 439,000
Net Cash Provided by Financing Activities 7,325,907 1,100,299
Effect of Exchange Rate Changes on Cash 98,946 128,051
Net Increase in Cash 5,332,912 151,564
Cash - Beginning of Period 134,536 40,378
Cash - End of Period 5,467,448 191,942
Supplemental Disclosures of Cash Flow Information:    
Interest paid 325,402 58,147
Income taxes paid
Non-Cash Investing and Financing Activity    
Common stock and warrants issued upon exchange of debt and accrued interest 1,422,068
Series B Preferred stock converted to common stock 9,010,824
Reclassification of deferred offering cost to additional paid in capital 67,016
Common stock and warrants issued to underwriter in public offering $ 297,963
[1] Includes gross proceeds of $8,002,004, less offering costs of $715,000.